Revolutionizing cell culture with our Swingo bioreactor

Bioscibex is a biotech hardware startup developing next-generation single-use bioreactors that simplify and automate cell culture. Our first product, Swingo, reduces the traditional 7-step cell culture process to just 2 steps, lowering contamination risk, manual handling, and CapEx. With a working volume range of 30 mL to 30 L (expandable), it supports R&D to manufacturing applications. We partner with contract manufacturers to scale efficiently, while retaining customer engagement. Backed by CHF 1M in funding and early interest from major biopharma players, Bioscibex is preparing for a commercial launch in Q2 2026.